Ikarian Capital, LLC Agenus Inc Transaction History

Ikarian Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.3 - $2.64 $141,612 - $287,583	-108,933 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$2.35 - $3.47 $13,491 - $19,921	5,741 Added 5.56%	108,933 $267,000
Q3 2021 Nov 15, 2021	SELL	$4.98 - $6.63 $3,241 - $4,316	-651 Reduced 0.63%	103,192 $542,000
Q2 2021 Aug 16, 2021	SELL	$2.56 - $5.49 $1.47 Million - $3.16 Million	-575,000 Reduced 84.7%	103,843 $570,000
Q1 2021 May 17, 2021	SELL	$2.69 - $5.25 $729,412 - $1.42 Million	-271,157 Reduced 28.54%	678,843 $1.85 Million
Q3 2020 Nov 16, 2020	BUY	$2.98 - $5.2 $2.83 Million - $4.94 Million	950,000 New	950,000 $3.8 Million

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.